ebselen has been researched along with Atherogenesis in 6 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of the GPx1-mimetic ebselen on diabetes-associated atherosclerosis and renal injury in a model of increased oxidative stress." | 3.76 | Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. ( Chew, P; Cooper, ME; Coughlan, MT; de Haan, JB; Jandeleit-Dahm, KA; Pete, J; Rosenfeldt, F; Stefanovic, N; Thomas, MC; Yuen, DY, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, SM | 1 |
| Sharma, A | 1 |
| Yuen, DY | 3 |
| Stefanovic, N | 3 |
| Krippner, G | 1 |
| Mugesh, G | 1 |
| Chai, Z | 1 |
| de Haan, JB | 3 |
| Phinikaridou, A | 1 |
| Andia, ME | 1 |
| Passacquale, G | 1 |
| Ferro, A | 1 |
| Botnar, RM | 1 |
| Chew, P | 2 |
| Koh, P | 1 |
| Febbraio, MA | 1 |
| Kola, I | 1 |
| Cooper, ME | 2 |
| Pete, J | 1 |
| Coughlan, MT | 1 |
| Jandeleit-Dahm, KA | 1 |
| Thomas, MC | 1 |
| Rosenfeldt, F | 1 |
| Park, JG | 1 |
| Yoo, JY | 1 |
| Jeong, SJ | 1 |
| Choi, JH | 1 |
| Lee, MR | 1 |
| Lee, MN | 1 |
| Hwa Lee, J | 1 |
| Kim, HC | 1 |
| Jo, H | 1 |
| Yu, DY | 1 |
| Kang, SW | 1 |
| Rhee, SG | 1 |
| Lee, MH | 1 |
| Oh, GT | 1 |
| Harkewicz, R | 1 |
| Hartvigsen, K | 1 |
| Almazan, F | 1 |
| Dennis, EA | 1 |
| Witztum, JL | 1 |
| Miller, YI | 1 |
6 other studies available for ebselen and Atherogenesis
| Article | Year |
|---|---|
The modified selenenyl amide, M-hydroxy ebselen, attenuates diabetic nephropathy and diabetes-associated atherosclerosis in ApoE/GPx1 double knockout mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Azoles; Cell Line; Diabetes Mellitus, Experimental; Dia | 2013 |
Noninvasive MRI monitoring of the effect of interventions on endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent.
Topics: Albumins; Animals; Anti-Bacterial Agents; Antioxidants; Atherosclerosis; Azoles; Contrast Media; End | 2013 |
Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.
Topics: Administration, Oral; Animals; Antioxidants; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Apo | 2009 |
Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse.
Topics: Aldehydes; Animals; Antioxidants; Apolipoproteins E; Atherosclerosis; Azoles; Diabetes Mellitus, Exp | 2010 |
Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice.
Topics: Animals; Antioxidants; Aorta; Apolipoproteins E; Atherosclerosis; Azoles; Bone Marrow Cells; Bone Ma | 2011 |
Cholesteryl ester hydroperoxides are biologically active components of minimally oxidized low density lipoprotein.
Topics: Animals; Apolipoproteins E; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Arachidonic | 2008 |